Suppr超能文献

临床前模型中膳食ω-3多不饱和脂肪酸、肥胖与肠道微生物群之间的相互作用:随机对照试验的系统评价

Interaction between dietary omega-3 polyunsaturated fatty acids, obesity and gut microbiota in preclinical models: A systematic review of randomized controlled trials.

作者信息

Cao Bing, Sun Yutong, Lam Chifong, Chen Yalin, Dri Christine E, McIntyre Roger S

机构信息

School of Psychology and Key Laboratory of Cognition and Personality (Ministry of Education), Southwest University, Chongqing, People's Republic of China.

National Demonstration Center for Experimental Psychology Education (Southwest University), Chongqing, People's Republic of China.

出版信息

Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16535.

Abstract

Emerging research underscores the potential of omega-3 polyunsaturated fatty acids (PUFAs) in weight reduction and modulation of the gut microbiota. The current review systematically examines the effects of omega-3 PUFA supplementation on body weight regulation and gut microbiota modulation in high-fat diet (HFD)-induced obesity models. The study protocol was registered with PROSPERO (CRD42024559835). Systematic searches were conducted from database inception to May 2025 on PubMed/Embase, Web of Science and selected reference lists. A total of 32 trials were included, with 25 studies employing a HFD along with dietary omega-3 PUFA supplementation and 7 studies with a HFD prior to dietary omega-3 PUFA supplementation. Omega-3 PUFA interventions consistently demonstrated attenuation of HFD-induced weight gain and adiposity, though body weight remained elevated compared to low-fat diet controls. Omega-3 PUFA supplementation also induced significant gut microbiota compositional changes. Specifically, omega-3 PUFAs effectively reduced the Firmicutes/Bacteroidetes (F/B) ratio, reversing a hallmark feature of HFD-induced dysbiosis. Enrichment of beneficial taxa, such as Akkermansia muciniphila, Bifidobacterium and Lactobacillus, was consistently observed, correlating with enhanced short-chain fatty acid (SCFA) production, improved gut barrier integrity and reduced systemic inflammation. Concurrently, omega-3 PUFAs suppressed pathogenic bacteria, such as Desulfovibrio and Lachnoclostridium, which are associated with endotoxaemia and metabolic dysfunction. These preclinical evidence suggest the potential of omega-3 PUFAs as a promising dietary intervention for obesity management through gut microbiota modulation. However, variability in outcomes across studies emphasizes the need for further investigation into the optimal duration, dosage and sources of omega-3 supplementation. Moreover, the synergistic effects of omega-3 PUFA supplements and lifestyle interventions, such as high-intensity interval training (HIIT), which further regulates microbial composition and improves metabolic outcomes, are also highly promising.

摘要

新兴研究强调了omega-3多不饱和脂肪酸(PUFAs)在减轻体重和调节肠道微生物群方面的潜力。本综述系统地研究了在高脂饮食(HFD)诱导的肥胖模型中,补充omega-3多不饱和脂肪酸对体重调节和肠道微生物群调节的影响。该研究方案已在国际前瞻性系统评价注册平台(PROSPERO)注册(注册号:CRD42024559835)。从数据库建立到2025年5月,在PubMed/Embase、Web of Science以及选定的参考文献列表中进行了系统检索。共纳入32项试验,其中25项研究采用高脂饮食并补充膳食omega-3多不饱和脂肪酸,7项研究在补充膳食omega-3多不饱和脂肪酸之前采用高脂饮食。omega-3多不饱和脂肪酸干预始终显示出可减轻高脂饮食诱导的体重增加和肥胖,尽管与低脂饮食对照组相比体重仍有所升高。补充omega-3多不饱和脂肪酸还引起了肠道微生物群组成的显著变化。具体而言,omega-3多不饱和脂肪酸有效地降低了厚壁菌门/拟杆菌门(F/B)的比例,扭转了高脂饮食诱导的生态失调的一个标志性特征。持续观察到有益菌属的富集,如嗜黏蛋白阿克曼氏菌、双歧杆菌和乳酸杆菌,这与短链脂肪酸(SCFA)产量增加、肠道屏障完整性改善和全身炎症减轻相关。同时,omega-3多不饱和脂肪酸抑制了与内毒素血症和代谢功能障碍相关的病原菌,如脱硫弧菌和瘤胃球菌属。这些临床前证据表明,omega-3多不饱和脂肪酸作为一种有前景的饮食干预手段,通过调节肠道微生物群来管理肥胖具有潜力。然而,各研究结果的差异强调需要进一步研究omega-3补充剂的最佳持续时间、剂量和来源。此外,omega-3多不饱和脂肪酸补充剂与生活方式干预(如高强度间歇训练(HIIT))的协同作用也非常有前景,高强度间歇训练可进一步调节微生物组成并改善代谢结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验